AI-generated summary
The authors pooled 14 randomized controlled trials of repeated low-level red-light therapy compared with single-vision spectacles in children and adolescents with myopia. They report that red-light therapy was associated with slower axial length growth and slower refraction progression over 1 to 12 months, with substantial heterogeneity. The authors note that long-term safety, sustained efficacy and optimal protocols still need confirmation.
- Participants
- 1,942
- Studies included
- 14
- Who or what was studied
- Children and adolescents with myopia
- Limits stated in the abstract
- The abstract notes substantial heterogeneity for axial length and refraction outcomes and that long-term safety, sustained efficacy and optimal protocols require further study.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Myopia, Repeated low-level red light, Meta-analysis, Systematic review, Heterogeneity, Confidence interval, Trial registration. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.